Mary Ann Anderson
The Royal Melbourne Hospital(AU)Peter MacCallum Cancer Centre(AU)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Geriatric Care and Nursing Homes, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia(2015)1,861 cited
- → Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma(2017)745 cited
- → Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma(2018)424 cited
- → Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia(2018)417 cited
- → The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs(2021)333 cited
- → The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism(2016)324 cited